Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB25FWADW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,125
Award facts
- Contract value 100% obligated
- $3,124.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is a delivery order valued at $3,124.68 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of MIRENA 52 MG SYSTEMS, a specialized pharmaceutical product, with a completion date of April 23, 2025.
DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.
The contract award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA through its contract awards.
Quick answers
Who was awarded contract SPE2DB25FWADW?
SPE2DB25FWADW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 2, 2025.
How much is contract SPE2DB25FWADW worth?
The government has obligated $3,125 on SPE2DB25FWADW.
Is contract SPE2DB25FWADW an order under another contract?
Yes. SPE2DB25FWADW is a delivery order under SPE2DB25D9322, an indefinite delivery contract.
Was contract SPE2DB25FWADW competed?
The extent of competition for SPE2DB25FWADW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award